Sana Karam, MD, PhD retweeted
Now in @JAMAOnc:
We report 5y outcomes post 30 Gy elective RT (total 70 Gy CCRT) for 276 pts w/ HPV-related OPC #hncsm at @MSKCancerCenter #radonc
LRC 97.0%
OS 90.8%
PFS 85.9%
DMFS 91.2%
@imrtlee @xrtGenomics @seanmmcbride @CJTsaiMDPhD @EChrisDee
👉 shorturl.at/liqpP
Sana Karam, MD, PhD retweeted
Asking patients to take endocrine therapy for 5+ years is easier said than done.
We found that maintaining long-term adherence can be challenging for patients with breast cancer, particularly those who omit radiation.
@WashUMedRadOnc @washumedicine @SitemanCenter
News from #ASTRO26: Real-world data indicate lower adherence rates for breast cancer endocrine therapy when radiation therapy is omitted
Nationwide insurance claims analysis finds fewer than 30% of patients remained adherent for five years after lumpectomy.
As seen in @Inside_PM, @AuntMinnie, HealthDay News, @cure_today & more. Presented by Shannon Jiang, MD.
Learn more: bit.ly/4ywQlUV
@WashUMedRadOnc @ShannonJiangMD
Sana Karam, MD, PhD retweeted
🚨‼️Happening now - technology driven strategies for HNSCC.
First talk - @imrtlee on FMISO pooled analyses.
#ASTRO26
@ASTRO_org
@xrtGenomics @seanmmcbride @MSK_RadOnc
Sana Karam, MD, PhD retweeted
👏⚡️Dr. Huang from Sun Yat-Sen presented stellar 10yr Outcomes of Elective Upper vs. Whole-Neck RT for the Uninvolved Neck in NPC with preRT high EBV viral load!
#ASTRO26
@ASTRO_org @DavidSherMD @KaramLab @ScottBratman
Sana Karam, MD, PhD retweeted
🦠💡Next up - TRINITY trial presented by Zachary Zumsteg at @CedarsSinai, investigating reduced dose/volume CRT after TORS with excellent 2-yr PFS.
#ASTRO26 @ASTRO_org
@xrtGenomics @DanielMaMD @RobertFerrisMD @drdavidpalma
Sana Karam, MD, PhD retweeted
2026 ASTRO Fellow Spotlight Series:
Congratulations to Carmen Bergom, MD, PhD, from the Washington University School of Medicine on being named a 2026 ASTRO Fellow!
We look forward to recognizing you at #ASTRO26.
View the list of 2026 Fellows: bit.ly/4pTnnM8
@carmenbergom @WashUMedRadOnc @washumedicine @SitemanCenter
Sana Karam, MD, PhD retweeted
Big news in our Div of Medical Physics!
Our #medphys MS & Certificate programs have been reaccredited by CAMPEP & our PhD program has been granted initial accreditation!! WashU now has a full complement of CAMPEP-accredited Medical Phys training programs! bit.ly/4ca63wX
Sana Karam, MD, PhD retweeted
It is our pleasure to announce that Andrés Bur, MD, FACS will be joining WashU Medicine as Chief of the Division of Head and Neck Surgery in the Department of Otolaryngology–Head & Neck Surgery!
Please join us in congratulating Dr. Bur!
Sana Karam, MD, PhD retweeted
Stoked to share our new paper w/ @TiroshLab in @NatureGenet! Using spatial multi-omics we characterized two distinct modes of p-EMT in HNSCC, each with their own distinct ecosystems and drivers. #SpatialTranscriptomics #HNSCC #Visium #CODEX #EMT
nature.com/articles/s41588-0…
Sana Karam, MD, PhD retweeted
Excited to share our new work by Jay Park @janghyun_park_ and friends! Jay found lymphoid structures in the skull bone marrow that seem to be serving immune hub role for the brain... brain, after all, may not be using "common lymph nodes" but rather has its own unique immune hubs and Jay showed their role in brain tumors... but their role in likely much more than that. This is a long paper but it is worth the read || nature.com/articles/s41586-0…
Sana Karam, MD, PhD retweeted
Congratulations to @jmmrad! He will be awarded tonight at #AAPMcomp2026 with honorary membership in @aapmHQ for his support for the mission and goals of AAPM through leadership and advocacy! 🙌
Sana Karam, MD, PhD retweeted
Fantastic presentation by @Nikhil_Rm_MDPhD on an exciting ancillary proposal of NRG-CC001 studying brain aging at the @NRGonc scientific session. @WashUMedRadOnc
Sana Karam, MD, PhD retweeted
Every Wednesday, we are spotlighting women who are making a difference in the #LungCancer community – in labs, at hospitals, and by sharing their stories.
Women like Aria Vaishnavi, PhD, a researcher who is working to understand oncogene-driven disease progression and radon-induced lung cancer.
For more information about women and lung cancer, visit LCRF.org/women.
#WomenWednesday #ResearchMatters
Sana Karam, MD, PhD retweeted
These skilled clinicians & researchers are dedicated to patients, constantly improving the radiation therapies that help inform better cancer care. We are thrilled to congratulate them on their faculty promotions as they take next steps in their careers. bit.ly/4gTnchn
Sana Karam, MD, PhD retweeted
Happy New Academic Year!
We are excited to welcome four residents who begin their #radonc training with us today!
Julia Balmaceda, MD, Keegan Christensen, MD, Christopher Cronkite, MD, PhD & Nisitha Sengottuvel, MD, PhD - welcome to the team!
Sana Karam, MD, PhD retweeted
Please see our message regarding the passing of Dr. Maura Gillison. Our thoughts are with her family, friends, and loved ones during this difficult time. Read the message here: conta.cc/4euSx8O
Sana Karam, MD, PhD retweeted
Beautiful evening celebrating our residency grads @mobotgarden! Congratulations to all graduates & their families on this huge milestone. We are excited for the new endeavors in your future and how your courageous critical thinking will transform the lives of patients everywhere!
Sana Karam, MD, PhD retweeted
It's #ClinicalTrialsDay and we are grateful to our team who help connect treatments to the patients who need them.
#CTD2026 #ResearchRising









































